Curative Biotechnology, Inc. filed its S-1 on Apr 15, 2022 for the period ending Dec 31, 2021. In this report its auditor, Daszkal Bolton LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | -7.24% | -20.00% | -6.10% |
05-06 | Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
1st Jan change | Capi. | |
---|---|---|
-6.10% | 18.07M | |
+33.50% | 49.46B | |
+1.78% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.58% | 26.61B | |
-21.64% | 18.64B | |
+7.88% | 13.16B | |
+29.66% | 12.55B | |
+23.43% | 12.1B |
- Stock Market
- Equities
- CUBT Stock
- News Curative Biotechnology, Inc.
- Curative Biotechnology, Inc. Auditor Raises 'Going Concern' Doubt